Loading...
Organogenesis Holdings Inc.
ORGO•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.03
$0.28(5.89%)
Organogenesis Holdings Inc. (ORGO) Financial Performance & Income Statement Overview
Review Organogenesis Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
11.29%
↑ 11.29%
Operating Income Growth
-110.24%
↓ 110.24%
Net Income Growth
-82.59%
↓ 82.59%
Operating Cash Flow Growth
-54.04%
↓ 54.04%
Operating Margin
-5.27%
↓ 5.27%
Gross Margin
74.89%
↑ 74.89%
Net Profit Margin
-4.06%
↓ 4.06%
ROE
-6.37%
↓ 6.37%
ROIC
-6.01%
↓ 6.009%
Organogenesis Holdings Inc. (ORGO) Income Statement & Financial Overview
Review Organogenesis Holdings Inc.'s (ORGO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $126.66M | $115.18M | $130.23M | $109.98M |
| Cost of Revenue | $31.05M | $26.80M | $33.60M | $32.36M |
| Gross Profit | $95.61M | $88.38M | $96.63M | $77.62M |
| Gross Profit Ratio | $0.75 | $0.77 | $0.74 | $0.71 |
| R&D Expenses | $11.53M | $10.34M | $15.59M | $12.81M |
| SG&A Expenses | $73.86M | $71.80M | $76.54M | $66.15M |
| Operating Expenses | $85.39M | $82.14M | $92.13M | $81.47M |
| Total Costs & Expenses | $116.44M | $108.94M | $121.33M | $113.83M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $471000.00 | $620000.00 | $514000.00 |
| Depreciation & Amortization | $27000.00 | $4.40M | $4.20M | $6.18M |
| EBITDA | $10.22M | $10.70M | -$9.72M | $144000.00 |
| EBITDA Ratio | $0.08 | $0.09 | -$0.07 | $0.001 |
| Operating Income | $10.22M | $6.24M | -$13.89M | -$3.85M |
| Operating Income Ratio | $0.08 | $0.05 | -$0.11 | -$0.04 |
| Other Income/Expenses (Net) | $34000.00 | -$419000.00 | -$648000.00 | -$491000.00 |
| Income Before Tax | $10.25M | $5.82M | -$14.54M | -$4.34M |
| Income Before Tax Ratio | $0.08 | $0.05 | -$0.11 | -$0.04 |
| Income Tax Expense | $2.58M | -$6.51M | $2.50M | -$2.24M |
| Net Income | $7.67M | $12.33M | -$17.04M | -$2.10M |
| Net Income Ratio | $0.06 | $0.11 | -$0.13 | -$0.02 |
| EPS | $0.05 | $0.09 | -$0.13 | -$0.02 |
| Diluted EPS | $0.04 | $0.09 | -$0.13 | -$0.02 |
| Weighted Avg Shares Outstanding | $131.67M | $132.58M | $132.57M | $131.86M |
| Weighted Avg Shares Outstanding (Diluted) | $132.16M | $133.93M | $132.57M | $131.86M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan